Skip to main content
Cancer Cell International logoLink to Cancer Cell International
. 2013 Aug 15;13:80. doi: 10.1186/1475-2867-13-80

Correction: Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy

Miceala Martinez 1, Nadia Ono 1, Marina Planutiene 2, Kestutis Planutis 2, Edward L Nelson 1, Randall F Holcombe 2,
PMCID: PMC3751084  PMID: 23945146

Correction

After publication of the original article [1] it came to the publishers attention that the article was incorrectly published as an Editorial instead of the correct article type; Primary Research. We apologise for any inconvenience this has caused.

Contributor Information

Miceala Martinez, Email: micaelam@uci.edu.

Nadia Ono, Email: nnono@ucdavis.edu.

Marina Planutiene, Email: marina.planoutene@mssm.edu.

Kestutis Planutis, Email: kiastoutis.planoutis@mssm.edu.

Edward L Nelson, Email: enelson@uci.edu.

Randall F Holcombe, Email: randall.holcombe@mssm.edu.

References

  1. Martinez M, Ono N, Planutiene M, Planutis K, Nelson EL, Holcombe RF, Guo Y, Hou J, Luo Y, Wang D. Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy. Cancer Cell Int. 2012;12:2. doi: 10.1186/1475-2867-12-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Cell International are provided here courtesy of BMC

RESOURCES